Browse Medical Research Based on Condition

FOR ACNE

FOR ADD / ADHD

FOR ADDICTION

FOR ALS

FOR ALZHEIMERS

 FOR ALZHEIMERSThe therapeutic potential of the endocannabinoid system for Alzheimer’s disease
 FOR ALZHEIMERSEndocannabinoid signalling in Alzheimer’s disease
 FOR ALZHEIMERSA molecular link between the active component of marijuana and Alzheimer’s disease pathology
 FOR ALZHEIMERSNeuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells
 FOR ALZHEIMERSThe Potential Therapeutic Effects of THC on Alzheimer’s Disease
 FOR ALZHEIMERSThe Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease
 FOR ALZHEIMERSCannabinoids for the treatment of dementia
 FOR ALZHEIMERSCannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression
 FOR ALZHEIMERSCannabidiol: A promising drug for neurodegenerative disorders?
 FOR ALZHEIMERSCannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
 FOR ALZHEIMERSThe role of the endocannabinoid system in Alzheimer’s disease: facts and hypotheses
 FOR ALZHEIMERSThe role of phytochemicals in the treatment and prevention of dementia
 FOR ALZHEIMERSCannabinoids for the treatment of dementia
 FOR ALZHEIMERSCannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement
 FOR ALZHEIMERSCannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
 FOR ALZHEIMERSCan Marijuana Prevent Alzheimer’s?

FOR ANOREXIA

FOR ANXIETY

FOR ATHEROSCLEROSIS

FOR ARTHRITIS

FOR ASTHMA

FOR AUTISM

FOR BIPOLAR AFFECTIVE DISORDER

FOR CANCER - GENERAL

FOR CANCER - LUNG

FOR CANCER - PROSTATE/COLON

FOR CANCER - BREAST

FOR CANCER - BRAIN

FOR CANCER - LEUKEMIA

FOR CANCER - SKIN

FOR CANCER - ENDOCRINE

FOR CANCER - BLADDER

FOR CANCER - PAIN RELIEF

FOR CROHNS & COLITIS

FOR DEPRESSION

FOR ENDOCRINE DISORDERS

 FOR ENDOCRINE DISORDERSEndocannabinoid system participates in neuroendocrine control of homeostasis
 FOR ENDOCRINE DISORDERSThe emerging role of the endocannabinoid system in endocrine regulation and energy balance
 FOR ENDOCRINE DISORDERSEndocannabinoids in endocrine and related tumours
 FOR ENDOCRINE DISORDERSRole of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas
 FOR ENDOCRINE DISORDERSThe role of the endocannabinoid system in the neuroendocrine regulation of energy balance
 FOR ENDOCRINE DISORDERSHemp Extract for children with Dravet’s and intractable seizures
 FOR ENDOCRINE DISORDERSReport of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy
 FOR ENDOCRINE DISORDERSMedicinal marijuana stops seizures, brings hope to a little girl
 FOR ENDOCRINE DISORDERSCannabinoids for epilepsy
 FOR ENDOCRINE DISORDERSCannabis, cannabidiol, and epilepsy – From receptors to clinical response
 FOR ENDOCRINE DISORDERSThe non-psychotropic plant cannabinoids, cannabidivarin and cannabidiol, activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability
 FOR ENDOCRINE DISORDERSChronic administration of cannabidiol to healthy volunteers and epileptic patients
 FOR ENDOCRINE DISORDERSEndocannabinoid system protects against cryptogenic seizures
 FOR ENDOCRINE DISORDERSSeizing an opportunity for the endocannabinoid system
 FOR ENDOCRINE DISORDERSCannabidiol: promise and pitfalls
 FOR ENDOCRINE DISORDERSCannabidivarin suppressespentylenetetrazole (PTZ)-inducedincreases in epilepsy-related gene expression
 FOR ENDOCRINE DISORDERSCannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures
 FOR ENDOCRINE DISORDERSCannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo
 FOR ENDOCRINE DISORDERSHypnotic and antiepileptic effects of cannabidiol
 FOR ENDOCRINE DISORDERSThe cannabinoids as potential antiepileptics
 FOR ENDOCRINE DISORDERSCannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats

FOR FIBROMYALGIA

FOR GLAUCOMA

FOR HEART DISEASE

FOR HUNTINGTONS DISEASE

FOR INFLAMMATION

FOR IRRITABLE BOWEL SYNDROME

FOR KIDNEY DISEASE

FOR LIVER DISEASE

FOR METABOLIC SYNDROME

FOR MIGRAINES

FOR MOOD DISORDERS

FOR MOTION SICKNESS

FOR MULTIPLE SCLEROSIS

FOR NAUSEA

FOR NEURODEGENERATION

FOR NEUROPATHIC PAIN

 FOR NEUROPATHIC PAINMeta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
 FOR NEUROPATHIC PAINSativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
 FOR NEUROPATHIC PAINCannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine
 FOR NEUROPATHIC PAINSativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
 FOR NEUROPATHIC PAINCannabinoids for neuropathic pain
 FOR NEUROPATHIC PAINNeuropathic orofacial pain: Cannabinoids as a therapeutic avenue
 FOR NEUROPATHIC PAINOromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial
 FOR NEUROPATHIC PAINThe non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain
 FOR NEUROPATHIC PAINVanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation
 FOR NEUROPATHIC PAINCannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
 FOR NEUROPATHIC PAINAntihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: Mechanisms involved
 FOR NEUROPATHIC PAINNon-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action
 FOR NEUROPATHIC PAINCannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
 FOR NEUROPATHIC PAINRole of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes
 FOR NEUROPATHIC PAINCannabinoids in the management of difficult to treat pain
 FOR NEUROPATHIC PAINMulticenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:Hemp extract and THC extract in patients with intractable cancer-related pain
 FOR NEUROPATHIC PAINMarijuana extract helps prevent chemo pain
 FOR NEUROPATHIC PAINPot users less likely to take painkillers

FOR OBESITY

FOR OCD

FOR PARKINSONS DISEASE

FOR PRION

FOR PTSD

 FOR PTSDThe endocannabinoid system provides an avenue for evidence-based treatment development for PTSD
 FOR PTSDReductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks
 FOR PTSDEnhancing cannabinoid neurotransmission augments the extinction of conditioned fear
 FOR PTSDCannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors
 FOR PTSDStress switches cannabinoid type-1 (CB1) receptor-dependent plasticity from LTD to LTP in the bed nucleus of the stria terminalis
 FOR PTSDMitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence
 FOR PTSDCannabinoid modulation of fear extinction brain circuits: A novel target to advance anxiety treatment
 FOR PTSDThe endocannabinoid system and extinction learning
 FOR PTSDA current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: potential extinction enhancers
 FOR PTSDCannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit
 FOR PTSDNon-antidepressant long-term treatment in post-traumatic stress disorder
 FOR PTSDThe anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: Involvement of the endocannabinoid system
 FOR PTSDModulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors

FOR RHEUMATISM

FOR SCHIZOPHRENIA

FOR SICKLE CELL ANEMIA

FOR SKIN CONDITIONS

FOR SLEEP DISORDERS

FOR SPINAL CORD INJURY

FOR STRESS

FOR STROKE/TBI